Neuren Pharmaceuticals Annual Report 2023

ADDITIONAL INFORMATION CONTINUED TWENTY LARGEST HOLDERS OF QUOTED ORDINARY SHARES Number of ordinary shares % of issued share capital 1 HSBC CUSTODY NOMINEES (AUSTRALIA) LIMITED 22,507,287 17.65 2 J P MORGAN NOMINEES AUSTRALIA PTY LIMITED 12,099,419 9.49 3 CITICORP NOMINEES PTY LIMITED 11,687,108 9.17 4 NATIONAL NOMINEES LIMITED 4,166,698 3.27 5 CAMERON RICHARD PTY LTD 4,123,084 3.23 6 BNP PARIBAS NOMS PTY LTD 3,584,206 2.81 7 STUART ANDREW PTY LTD 2,633,787 2.07 8 ESSEX CASTLE LIMITED 2,387,678 1.87 9 SMITHLEY SUPER PTY LTD 1,870,000 1.47 10 LINWIERIK SUPER PTY LTD 1,761,385 1.38 11 SHARESIES AUSTRALIA NOMINEE PTY LIMITED 1,435,555 1.13 12 BNP PARIBAS NOMINEES PTY LTD 796,367 0.62 13 FIRST COLBYCO PTY LTD 750,000 0.59 13 MJHFT PTY LTD 750,000 0.59 14 BNP PARIBAS NOMINEES PTY LTD ACF CLEARSTREAM 745,279 0.58 15 DR ROBIN LANCE CONGREVE 671,637 0.53 16 HSBC CUSTODY NOMINEES (AUSTRALIA) LIMITED - A/C 2 499,399 0.39 17 EMANCIPAYTE PTY LTD 470,756 0.37 18 NETWEALTH INVESTMENTS LIMITED 421,309 0.33 19 MR HE ZHAO 405,000 0.32 20 PFIZER INC 404,072 0.32 Total 74,170,026 58.17 Balance of share register 53,325,650 41.83 Total ordinary shares quoted on ASX 127,495,676 100.00 SUBSTANTIAL SECURITY HOLDERS The following have filed substantial holding notifications based on the last notice lodged on the ASX: Number held Percentage Milford Asset Management Limited 6,561,977 5.088% DISTRIBUTION OF SECURITY HOLDERS Listed ordinary shares Size of holding Number of ordinary shares % Number of holders % 100,001 and Over 92,527,908 72.57 124 1.49 10,001 to 100,000 23,600,151 18.51 790 9.47 5,001 to 10,000 4,360,478 3.42 580 6.95 1,001 to 5,000 5,436,028 4.26 2,169 25.99 1 to 1,000 1,571,111 1.23 4,681 56.10 Total 127,495,676 100.00 8,344 100.00 UNLISTED SECURITIES 2,250,000 Loan Funded Shares, held as treasury stock, with a weighted average exercise price of $1.84, with an expiry date of 13 July 2025. There are 3 holders of 100,001 and over. 2,120,000 Employee Share Scheme options, with a weighted average exercise price of $10.02, of which 970,000 have an expiry date of 3 February 2026, 450,000 have an expiry date of 8 July 2026 and 700,000 have an expiry date of 7 February 2029. There are 9 holders of 100,001 and over. Neuren Pharmaceuticals Limited Annual Report 2023 57

RkJQdWJsaXNoZXIy MjE2NDg3